Rechallenge after Clozapine-Induced Neutropenic Events: A Case Series
Year: 2026
Type: article
Study design: Observational Study
Abstract: Clozapine is highly effective for resistant schizophrenia but limited by neutropenia concerns. In this 30-year series, 27 patients discontinued clozapine and 13 were rechallenged; 61.5% were successfully maintained. No fatalities occurred, and index-episode severity did not predict outcomes. Rechallenge appears safe when guided by individualised risk-benefit assessment.
Source: Psychopharmacology Bulletin
DOI: 10.64719/pb.20782
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7213637745
